These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 25193855

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
    Matte I, Legault CM, Garde-Granger P, Laplante C, Bessette P, Rancourt C, Piché A.
    Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
    [Abstract] [Full Text] [Related]

  • 4. Ascites microenvironment conditions the peritoneal pre-metastatic niche to promote the implantation of ovarian tumor spheroids: Involvement of fibrinogen/fibrin and αV and α5β1 integrins.
    Laurent-Issartel C, Landras A, Agniel R, Giffard F, Blanc-Fournier C, Da Silva Cruz E, Habes C, Leroy-Dudal J, Carreiras F, Kellouche S.
    Exp Cell Res; 2024 Aug 01; 441(1):114155. PubMed ID: 39002689
    [Abstract] [Full Text] [Related]

  • 5. Targeting gonadotropin-releasing hormone receptor inhibits the early step of ovarian cancer metastasis by modulating tumor-mesothelial adhesion.
    Cheung LW, Yung S, Chan TM, Leung PC, Wong AS.
    Mol Ther; 2013 Jan 01; 21(1):78-90. PubMed ID: 23164934
    [Abstract] [Full Text] [Related]

  • 6. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
    Sawada K, Mitra AK, Radjabi AR, Bhaskar V, Kistner EO, Tretiakova M, Jagadeeswaran S, Montag A, Becker A, Kenny HA, Peter ME, Ramakrishnan V, Yamada SD, Lengyel E.
    Cancer Res; 2008 Apr 01; 68(7):2329-39. PubMed ID: 18381440
    [Abstract] [Full Text] [Related]

  • 7. The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.
    Schultz MJ, Holdbrooks AT, Chakraborty A, Grizzle WE, Landen CN, Buchsbaum DJ, Conner MG, Arend RC, Yoon KJ, Klug CA, Bullard DC, Kesterson RA, Oliver PG, O'Connor AK, Yoder BK, Bellis SL.
    Cancer Res; 2016 Jul 01; 76(13):3978-88. PubMed ID: 27216178
    [Abstract] [Full Text] [Related]

  • 8. A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread.
    Loessner D, Rizzi SC, Stok KS, Fuehrmann T, Hollier B, Magdolen V, Hutmacher DW, Clements JA.
    Biomaterials; 2013 Oct 01; 34(30):7389-400. PubMed ID: 23827191
    [Abstract] [Full Text] [Related]

  • 9. Activation of integrin β1 mediates the increased malignant potential of ovarian cancer cells exerted by inflammatory cytokines.
    Yang Z, Zhou X, Liu Y, Gong C, Wei X, Zhang T, Ma D, Gao Q.
    Anticancer Agents Med Chem; 2014 Oct 01; 14(7):955-62. PubMed ID: 24931361
    [Abstract] [Full Text] [Related]

  • 10. p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.
    Pon YL, Zhou HY, Cheung AN, Ngan HY, Wong AS.
    Cancer Res; 2008 Aug 15; 68(16):6524-32. PubMed ID: 18701475
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Wnt11 alters integrin and cadherin expression by ovarian cancer spheroids and inhibits tumorigenesis and metastasis.
    Azimian-Zavareh V, Hossein G, Ebrahimi M, Dehghani-Ghobadi Z.
    Exp Cell Res; 2018 Aug 01; 369(1):90-104. PubMed ID: 29753625
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.
    Torchiaro E, Lorenzato A, Olivero M, Valdembri D, Gagliardi PA, Gai M, Erriquez J, Serini G, Di Renzo MF.
    Oncotarget; 2016 Jan 05; 7(1):712-28. PubMed ID: 26625210
    [Abstract] [Full Text] [Related]

  • 20. Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids.
    Casey RC, Burleson KM, Skubitz KM, Pambuccian SE, Oegema TR, Ruff LE, Skubitz AP.
    Am J Pathol; 2001 Dec 05; 159(6):2071-80. PubMed ID: 11733357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.